Literature DB >> 11985525

A reduction in the number of peripheral CD28+CD8+T cells in the acute phase of influenza.

S Nabeshima1, M Murata, K Kikuchi, H Ikematsu, S Kashiwagi, J Hayashi.   

Abstract

Influenza patients show a high incidence of T lymphocytopenia in the acute phase of the illness. Since CD8+ T cells play an important role in influenza virus infection, we investigated which subset of CD8+ T cells was involved in this lymphocytopenia. CD8+ T cells from eight patients with influenza A were studied for lymphocyte count, surface marker, and intracellular IFN-gamma production in the acute (days 1-3) and recovery phases (days 9-12). Total and T lymphocyte counts in the acute phase were approximately three times less than in the recovery phase; however, the CD4/8 ratio was the same in both phases. The cell count reduction in the acute phase was attributed predominantly to the CD28+ CD8+ subset, compared with the CD28- CD8+ subset. The memory/activation marker CD45RO on the CD8+ T cells was assessed. The CD28+ CD45RO- subset, a naive phenotype, was reduced significantly in number in the acute phase compared with the recovery phase. The CD28+ CD45RO+ subset, a memory phenotype, was also reduced in the acute phase, but the reduction was not statistically significant. Intracellular IFN-gamma in the CD8+ subset after mitogenic stimulation was measured by flow cytometry; the percentage of CD28+ IFN-gamma-/CD8+ subset in the acute phase was significantly less than in the recovery phase. These results indicated that the predominant reduction of peripheral CD8+ T cells in the acute phase of influenza was from naive-type lymphocytes, suggesting that these quantitative and qualitative changes of CD8+ T cells in influenza are important for understanding the immunological pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985525      PMCID: PMC1906404          DOI: 10.1046/j.1365-2249.2002.01819.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division.

Authors:  D Hamann; S Kostense; K C Wolthers; S A Otto; P A Baars; F Miedema; R A van Lier
Journal:  Int Immunol       Date:  1999-07       Impact factor: 4.823

Review 2.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Authors:  R H Schwartz
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

3.  Colorado tick fever as a hematologic problem.

Authors:  E S JOHNSON; V M NAPOLI; W C WHITE
Journal:  Am J Clin Pathol       Date:  1960-08       Impact factor: 2.493

4.  The blood picture in rubella; its place in diagnosis.

Authors:  F K HILLENBRAND
Journal:  Lancet       Date:  1956-07-14       Impact factor: 79.321

5.  Lymphocytopenia in rabbits following intravenous injection of influenzal virus.

Authors:  S HARRIS; W HENLE
Journal:  J Immunol       Date:  1948-05       Impact factor: 5.422

6.  Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells.

Authors:  T Takizawa; S Matsukawa; Y Higuchi; S Nakamura; Y Nakanishi; R Fukuda
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

7.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

Authors:  K Y Yuen; P K Chan; M Peiris; D N Tsang; T L Que; K F Shortridge; P T Cheung; W K To; E T Ho; R Sung; A F Cheng
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

8.  Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation.

Authors:  C Spaulding; W Guo; R B Effros
Journal:  Exp Gerontol       Date:  1999-08       Impact factor: 4.032

9.  Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.

Authors:  D N Posnett; J W Edinger; J S Manavalan; C Irwin; G Marodon
Journal:  Int Immunol       Date:  1999-02       Impact factor: 4.823

10.  CD28- T lymphocytes. Antigenic and functional properties.

Authors:  M Azuma; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

View more
  9 in total

Review 1.  The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-04-04       Impact factor: 3.402

2.  Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists.

Authors:  Kapil Bahl; Anette Hüebner; Roger J Davis; Raymond M Welsh
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

3.  TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination.

Authors:  Randall Toy; M Cole Keenum; Pallab Pradhan; Katelynn Phang; Patrick Chen; Chinwendu Chukwu; Lily Anh H Nguyen; Jiaying Liu; Sambhav Jain; Gabrielle Kozlowski; Justin Hosten; Mehul S Suthar; Krishnendu Roy
Journal:  J Control Release       Date:  2020-11-05       Impact factor: 9.776

4.  Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.

Authors:  Kamalakannan Rajasekaran; Va Xiong; Lee Fong; Jack Gorski; Subramaniam Malarkannan
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

Review 5.  Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.

Authors:  Liisa K Selin; Michael A Brehm; Yuri N Naumov; Markus Cornberg; Sung-Kwon Kim; Shalyn C Clute; Raymond M Welsh
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

6.  Useful clinical findings and simple laboratory data for the diagnosis of seasonal influenza.

Authors:  Hiroaki Takeoka; Ken Horibata; Tetsuya Hiyoshi; Ikuma Noge; Eishi Sakihara; Yusuke Sechi; Shota Okutsu; Hiroki Suzuyama; Shigeki Nabeshima
Journal:  J Gen Fam Med       Date:  2021-02-28

7.  Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.

Authors:  L Vanderbeke; P Van Mol; Y Van Herck; F De Smet; S Humblet-Baron; K Martinod; A Antoranz; I Arijs; B Boeckx; F M Bosisio; M Casaer; D Dauwe; W De Wever; C Dooms; E Dreesen; A Emmaneel; J Filtjens; M Gouwy; J Gunst; G Hermans; S Jansen; K Lagrou; A Liston; N Lorent; P Meersseman; T Mercier; J Neyts; J Odent; D Panovska; P A Penttila; E Pollet; P Proost; J Qian; K Quintelier; J Raes; S Rex; Y Saeys; J Sprooten; S Tejpar; D Testelmans; K Thevissen; T Van Buyten; J Vandenhaute; S Van Gassen; L C Velásquez Pereira; R Vos; B Weynand; A Wilmer; J Yserbyt; A D Garg; P Matthys; C Wouters; D Lambrechts; E Wauters; J Wauters
Journal:  Nat Commun       Date:  2021-07-05       Impact factor: 14.919

8.  A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.

Authors:  Rosanne W Wieten; Emile F F Jonker; Ester M M van Leeuwen; Ester B M Remmerswaal; Ineke J M Ten Berge; Adriëtte W de Visser; Perry J J van Genderen; Abraham Goorhuis; Leo G Visser; Martin P Grobusch; Godelieve J de Bree
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

Review 9.  Apoptosis and loss of virus-specific CD8+ T-cell memory.

Authors:  Raymond M Welsh; Kapil Bahl; Xiaoting Z Wang
Journal:  Curr Opin Immunol       Date:  2004-06       Impact factor: 7.486

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.